Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations

Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies

(2021) Israa Dib et al.   MOLECULAR BIOLOGY REPORTS

Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients

(2021) Camilla Ditlev Lindhardt Johannesen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study

(2021) Renato Quispe et al.   EUROPEAN HEART JOURNAL

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

(2021) Henry N Ginsberg et al.   EUROPEAN HEART JOURNAL

Keeping remnants in perspective

(2021) Jan Borén et al.   EUROPEAN HEART JOURNAL

APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups

(2021) Shiwali Goyal et al.   Lipids in Health and Disease

Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk

(2021) Jean-Claude Tardif et al.   EUROPEAN HEART JOURNAL

New Therapies for Lowering Triglyceride-Rich Lipoproteins

(2021) Robert S. Rosenson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease

(2020) Alan Chait et al.   DIABETES

Causes and Consequences of Hypertriglyceridemia

(2020) Chris J. Packard et al.   Frontiers in Endocrinology

Remnant lipoproteins

(2020) Carlos A. Aguilar Salinas et al.   CURRENT OPINION IN LIPIDOLOGY

The next generation of triglyceride-lowering drugs

(2020) Laurens F. Reeskamp et al.   CURRENT OPINION IN LIPIDOLOGY

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans

(2020) Jan Borén et al.   Frontiers in Endocrinology

ApoCIII: A multifaceted protein in cardiometabolic disease

(2020) D’Erasmo Laura et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes

(2020) Marja-Riitta Taskinen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease

(2020) Edward K Duran et al.   CLINICAL CHEMISTRY

Lipoprotein Lipase and Its Regulators: An Unfolding Story

(2020) Shuangcheng Alivia Wu et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics

(2019) E. Björnson et al.   JOURNAL OF INTERNAL MEDICINE

Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD

(2019) Marja-Riitta Taskinen et al.   Current Atherosclerosis Reports

Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia

(2019) Martin Adiels et al.   DIABETES OBESITY & METABOLISM

A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals

(2019) Mie Balling et al.   ATHEROSCLEROSIS

Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐ and hypertriglyceridemic human subjects

(2019) E. Björnson et al.   JOURNAL OF INTERNAL MEDICINE

Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism

(2018) Bastian Ramms et al.   CURRENT OPINION IN LIPIDOLOGY

Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism

(2018) Gissette Reyes-Soffer et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Association of Genetically Enhanced Lipoprotein Lipase–Mediated Lipolysis and Low-Density Lipoprotein Cholesterol–Lowering Alleles With Risk of Coronary Disease and Type 2 Diabetes

(2018) Luca A. Lotta et al.   JAMA Cardiology

Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity

(2017) M.-R. Taskinen et al.   JOURNAL OF INTERNAL MEDICINE

Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity

(2017) Danish Saleheen et al.   NATURE

Increasing Lipolysis and Reducing Atherosclerosis

(2017) Alan R. Tall   NEW ENGLAND JOURNAL OF MEDICINE

Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal ObesitySignificance

(2015) Jan Borén et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Extreme Nonfasting Remnant Cholesterol vs Extreme LDL Cholesterol as Contributors to Cardiovascular Disease and All-Cause Mortality in 90000 Individuals from the General Population

(2015) A. Varbo et al.   CLINICAL CHEMISTRY

The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia

(2015) Frank M. Sacks   CURRENT OPINION IN LIPIDOLOGY

Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia

(2015) Daniel Gaudet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apolipoprotein C-III: From Pathophysiology to Pharmacology

(2015) Giuseppe Danilo Norata et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

(2014) Anders Berg Jørgensen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

A rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans

(2014) Nicholas J. Timpson et al.   Nature Communications

Intrahepatic Role of Exchangeable Apolipoproteins in Lipoprotein Assembly and Secretion

(2012) Meenakshi Sundaram et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma

(2012) Lars Löfgren et al.   JOURNAL OF LIPID RESEARCH

Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype

(2010) Chunyu Zheng et al.   CIRCULATION

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

(2009) A. Hiukka et al.   DIABETES

Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry

(2009) C. S. Ejsing et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

(2008) T. I. Pollin et al.   SCIENCE

Plasma Apolipoprotein C-III Transport in Centrally Obese Men: Associations with Very Low-Density Lipoprotein Apolipoprotein B and High-Density Lipoprotein Apolipoprotein A-I Metabolism

(2007) Dick C. Chan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM